PlainPharmaWatch

CMS Open Payments · Program Year 2024

ReShape Lifesciences Inc.

ReShape Lifesciences Inc. reported $5,842.88 in payments to 15 physicians and teaching hospitals across 15 transactions.

See the rankings → How this is sourced
$5.8K
Total payments
15
Transactions
15
Recipients
−$34.2K
General Payments vs PY2023

ReShape Lifesciences Inc. reported $5,842.88 in payments to 15 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1698 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $389.53 per recipient across 2 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

ReShape Lifesciences Inc. pairs modest payment volume with a concentrated payment pattern focused on a handful of top recipients.

#1698
of 1,925 companies
0.0%
of all US industry payments
0.7%
paid to its single top recipient
2
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

ReShape Lifesciences Inc.'s CMS-reported General Payments decreased by $34.2K (−85.4%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: RESHAPE LIFESCIENCES INC.PY2023: RESHAPE LIFESCIENCES INC.PY2024: ReShape Lifesciences Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$40.1KPY2024$5.8K
PY2023
$40,057.06
PY2024
$5,842.88

How ReShape Lifesciences Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

ReShape Lifesciences Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$5,843 12th percentile higher than 12% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). This entry sits in this band. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for ReShape Lifesciences Inc.

In Program Year 2024, ReShape Lifesciences Inc. reported $5,842.88 in payments to 15 physicians and teaching hospitals across 15 individual transactions, an average of $389.53 per transaction and $389.53 per recipient. That total places ReShape Lifesciences Inc. at rank #1698 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 2-category general-payment breakdown below at $5.6K (95.8% of the company's reported total, 5 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads ReShape Lifesciences Inc.'s 2-category general-payment breakdown at $5.6K, 95.8% of the reported total.

How ReShape Lifesciences Inc. divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$5.6K2. Food and Beverage$242.88
Payment Type Amount Transactions
Consulting Fee $5.6K 5
Food and Beverage $242.88 10

Recipient Concentration in General Payments

The five largest recipient relationships account for $5,701.74 (97.6%) of $5,842.88 in this company's General Payments records across 12 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for ReShape Lifesciences Inc.

The five named recipients with the highest reported General Payments from this company

Christine Fielding$4.3KVafa Shayani$1.3KJeffrey Allen$39.80Jeffrey Holloway$30.97Amber Schulze$30.97
  1. 1

    Christine Fielding

    $4,287.50 across 4 reported transactions

  2. 2

    Vafa Shayani

    $1,312.50 across 1 reported transactions

  3. 3

    Jeffrey Allen

    $39.80 across 1 reported transactions

  4. 4

    Jeffrey Holloway

    $30.97 across 1 reported transactions

  5. 5

    Amber Schulze

    $30.97 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $389.53. Average per recipient: $389.53.

Total Amount

$5,842.88

Avg per Transaction

$389.53

Avg per Recipient

$389.53

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

ReShape Lifesciences Inc. Share

0.0%

#1698 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to ReShape Lifesciences Inc.

DentalEZ Alabama, Inc.

$5.9K 13 recipients

Perfuze Inc

$5.8K 5 recipients

Escala Medical Inc.

$6.0K 52 recipients

Dunamis Medical, LLC

$6.0K 48 recipients

Bridge to Life Ltd

$5.6K 9 recipients

Rare Disease Therapeutics, Inc.

$5.6K 104 recipients

Frequently Asked Questions

How much did ReShape Lifesciences Inc. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from ReShape Lifesciences Inc., totaling $5,842.88 across 15 transactions to physicians and hospitals.
How many physicians received payments from ReShape Lifesciences Inc.? ▾
15 physicians and teaching hospitals received payments from ReShape Lifesciences Inc. in 2024, averaging $389.53 per recipient.
What types of payments did ReShape Lifesciences Inc. make? ▾
General payments from ReShape Lifesciences Inc. span 2 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $5.6K, representing 95.8% of the company's reported total.
How does ReShape Lifesciences Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, ReShape Lifesciences Inc. ranks #1698 by total payment amount.
What is the average payment size from ReShape Lifesciences Inc.? ▾
ReShape Lifesciences Inc.'s 15 transactions to 15 recipients in 2024 averaged $389.53 per transaction.
Where does the payment data for ReShape Lifesciences Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download ReShape Lifesciences Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.